Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Severe Anemia: Indications for Blood Transfusion, Initial Work Up, a…

APP2APP Virtual Lectures, Inc

D. Thomas

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

How to Approach Anemia

Icahn School of Medicine at Mount Sinai

C. Cromwell

Anemia Case Discussion: Microcytic Hypochromic Anemia in Thalassemia

APP2APP Virtual Lectures, Inc

D. Thomas

Anemia Case Discussion: Anemia in Chronic Kidney Disease With B12 or…

APP2APP Virtual Lectures, Inc

D. Thomas

Case Discussion: Managing Anemia in a Patient With CLL & Metastatic …

Cleveland Clinic Taussig Cancer Institute

B. Estfan, K. McCrae, P. Caimi

Real-World Data of Ruxolitinib in Myelofibrosis Including Patients W…

Paola Guglielmelli

Final 48-Week Results of the APPLY-PNH Trial: Long-Term Efficacy & S…

Insights from 2023 ASH Annual Meeting

C. de Castro

Highlights in Red Cell and Platelet Disorders From ASH 2023

Insights from 2023 ASH Annual Meeting

M. Blinder

Anemia: Beyond Iron Deficiency!

Scripps Health

A. Goodman

Managing Heavy Menstrual Bleeding and Anemia in Adolescents

UChicago Medicine

J. De Jong

Anemia Case Discussions: Anemia Secondary to Hematologic Malignancy …

APP2APP Virtual Lectures, Inc

D. Thomas

EHA 2024 Insights: Impact of Anemia on Clinical Outcomes in MF Patie…

Insights from 2024 EHA Annual Meeting

H. Kathrin Al-Ali

Anemia Case Discussions: Anemia Secondary to Autoimmune Disorders

APP2APP Virtual Lectures, Inc

D. Thomas